Palmoplantar pustulosis
Recurring yellow-white sterile pustules, redness, brown spots, scale and fissures.
Palmoplantar pustulosis and psoriasis are related inflammatory skin diseases, but PPP is not the same clinical presentation as ordinary plaque psoriasis.
PPP causes recurring sterile pustules mainly on the palms and soles. Plaque psoriasis usually causes sharply defined, raised, scaly plaques and can affect many areas of the body. Palmoplantar psoriasis is plaque psoriasis specifically affecting hands and feet.
Written by Åsa Kärrman · Patient advocate and author · Last updated August 2026
Recurring yellow-white sterile pustules, redness, brown spots, scale and fissures.
Raised, well-defined inflammatory plaques with dry scale; pustules are not the main feature.
Confusion often begins because several different diagnoses contain the words “palmoplantar”, “pustular” or “psoriasis”.
A chronic, relapsing eruption of sterile pustules on palms and/or soles, usually with redness, brown macules, scale and fissures.
Plaque psoriasis affecting palms and soles. Skin is often sharply defined, thickened, dry and cracked; pustules are not necessarily present.
A rare, potentially serious condition with widespread pustules and systemic inflammation. It is not simply severe PPP.
The table describes common patterns. Individual cases can overlap, and diagnosis cannot be made from one feature alone.
| Feature | Palmoplantar pustulosis | Plaque psoriasis |
|---|---|---|
| Main lesion | Recurring sterile yellow-white pustules that dry into brown spots, scale and crusts. | Raised, well-defined inflammatory plaques with dry white or silvery scale. |
| Typical location | Primarily palms and soles. | Commonly elbows, knees, scalp, trunk and lower back, but any skin site can be affected. |
| Hands and feet | The defining location of PPP. | Can affect palms and soles as palmoplantar psoriasis. |
| Pustules | Characteristic. The fluid is typically sterile. | Not typical of ordinary plaque psoriasis. |
| Course | Repeated crops of pustules with overlapping active, drying and peeling phases. | Persistent or recurring plaques that may enlarge, clear or recur. |
| Smoking association | Very strong association; many patients are current or former smokers. | Smoking can worsen psoriasis, but the association is less distinctive than in PPP. |
| Sex pattern | Reported much more often in women, typically beginning in middle adulthood. | Affects all sexes; age of onset varies widely. |
| Genetics | Does not show the same strong association with the major plaque-psoriasis susceptibility locus HLA-Cw6/PSORS1. | HLA-Cw6 is an important risk factor, especially in early-onset plaque psoriasis. |
| Associated musculoskeletal disease | Associated with SAPHO syndrome and related osteoarticular inflammation in some patients. | Associated with psoriatic arthritis. |
| Treatment response | Often difficult to treat and may respond less reliably to biologics effective for plaque psoriasis. | Many well-established topical, phototherapy, systemic and biologic options are available. |
Palmoplantar psoriasis can resemble PPP because thick skin on the hands and feet often becomes red, dry, scaly and deeply fissured. The crucial difference is that plaque-type palmoplantar psoriasis is dominated by thickened plaques rather than recurring sterile pustules.
Fungal infection, dyshidrotic eczema and contact dermatitis may also resemble either condition.
Smoking is one of the strongest recognised associations with PPP. Some clinical sources report that up to 95% of patients smoke or previously smoked, although percentages vary between populations.
PPP and plaque psoriasis share some inflammatory mechanisms, but their genetic profiles are not identical. PPP is not strongly linked to the main PSORS1/HLA-Cw6 risk locus in the same way as plaque psoriasis.
Some guidelines classify PPP within psoriasis, while other expert groups and reviews describe it as a distinct clinical entity. That disagreement is why patients may hear different explanations.
Both conditions may be treated with potent topical corticosteroids, emollients, phototherapy and systemic medicines. The most suitable treatment depends on diagnosis, severity, other medical conditions and previous response.
PPP is often persistent and treatment-resistant. Options may include topical treatment, PUVA, oral retinoids and other systemic or immune-modulating medicines. Biologics used for plaque psoriasis do not always perform as reliably in PPP.
Plaque psoriasis has a broader evidence base and more established treatment pathways, including topical therapies, phototherapy, conventional systemic medicines and multiple targeted biologics.
Treatment availability and medicine approvals differ between countries. Do not start, stop or change prescribed treatment without speaking with the prescriber.
There is no single blood test that reliably separates PPP from psoriasis. Diagnosis is based on appearance, distribution, history and sometimes additional testing.
Are sterile pustules the dominant feature, or are there sharply defined plaques with thick scale?
PPP primarily affects palms and soles. Plaques on the scalp, elbows, knees or trunk may support a psoriasis diagnosis.
Nail changes occur in both. Joint, bone or chest-wall symptoms may alter the assessment and referral pathway.
Skin scraping or fungal culture can help exclude infection. Patch testing or biopsy may be useful when the diagnosis remains unclear.
PPP changes rapidly as pustules appear, dry and peel. Dated photographs from several stages can be more informative than the skin's appearance on one appointment day.
A person may have recurring pustules on palms or soles and plaque psoriasis on another body site. This does not make the palm-and-sole eruption identical to an ordinary plaque.
Early lesions can be difficult to classify. Follow-up, photographs, treatment response and additional skin findings may help refine the diagnosis.
Seek urgent medical assessment when pustules spread rapidly beyond the palms and soles, large areas of skin become red and painful, or you develop fever, chills, weakness or feel systemically unwell. Generalised pustular psoriasis can be a medical emergency.
Increasing heat, swelling, discharge or rapidly worsening pain may also indicate secondary infection or another diagnosis.
Before receiving a PPP diagnosis, I was given several different explanations for my skin, including eczema, scabies and fungal infection. The uncertainty delayed my understanding of what I was dealing with.
My experience can offer context, but it cannot diagnose another person's skin. A correct clinical assessment remains the foundation for appropriate treatment.